Daewoong Pharm to contemplate split off

Published: 2002-05-16 06:56:00

Updated: 2002-05-16 06:56:00

Daewoong Pharm says that based on the report of Samil Accounting Corporation, it is now contemplating a split off plan to be finalized next month, in a bid to cope with the rapidly changing market environment and promote the corporate restructuring, thereby maximizing the long-term corporate valu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK